Business Wire

IL-PROJECT44

4.3.2020 13:02:09 CET | Business Wire | Press release

Share
project44 Introduces First Ever Carrier Onboarding SLA to Accelerate Visibility Results for Shippers

According to Gartner Inc.’s recently released Market Guide for Real-Time Transportation Visibility Platforms , visibility is only possible with comprehensive network coverage and compliance. Today project44, the global leader in advanced visibility for shippers and logistics service providers, announced a new service level agreement (SLA) around full truckload carrier onboarding. This groundbreaking agreement demonstrates the technology provider’s commitment to results and offers a money-back guarantee.

Under the new carrier coverage SLA, project44 will guarantee that 90% of a shipper’s contracted truckload carriers in North America and Europe will be live within 30 days of starting implementation. With carrier compliance at the foundation of transportation visibility, this commitment will rapidly deliver upon the promise of real-time visibility and provide project44 customers a significant competitive advantage in today’s Delivery Economy.

“Carrier network coverage is the linchpin to visibility. Uline evaluated a variety of technology providers and knew that our full truckload visibility implementation would fail without adequate network coverage. It was very clear to us that p44 provided the largest carrier network along with the most scalable and automated onboarding process,” said Angelo Ventrone, VP of Logistics at Uline, the leading distributor of shipping, industrial and packaging materials in North America. “As a partner, they went above and beyond to ensure compliance, which has resulted in truckload tracking percentages of over 95%. Ultimately selecting project44 has enabled Uline to efficiently deliver on a differentiated customer experience.”

While this service level agreement is new to the industry, project44’s commitment to its carrier network is not. The visibility provider serves over 300 enterprise customers with the largest carrier network across North America and Europe. This includes connections to more than 760 ELD/telematics providers over more than 48 countries, and connections to 4.33 million drivers, 3.55 million trucks, and 800,000 fleets. Thanks to its automated onboarding application, the Network Management Center™, project44 enables customers to accelerate their time to value and immediately see the results of their visibility investment.

“Coop operates with more than 1,000 stores who all need deliveries on a weekly basis. For us to have the most efficient supply chain, we lacked an end-to-end overview of our carrier and subcontractor deliveries,” said Kennet Thorsen, Senior Distribution Manager at Coop Denmark A/S. “Our organization leveraged project44’s robust carrier network and world-class onboarding process to rapidly increase the ROI of our technology investment, streamline operations and better meet service goals towards our stores.”

project44's Network Management Center debuted in Europe over three years ago, driving unprecedented time-to-live with Truckload carriers. 48% of carriers achieve live status within one day, 81% within ten days – all through an automated, self-service cloud-based application. By combining project44’s automated tools and enterprise-grade implementation processes, the world’s leading ecommerce retailer, utilizing more than 2,500 different truckload providers across Europe, saw 95% connectivity in the first 45 days of working with project44. The commitment outlined in this SLA provides shippers of all sizes with the tools necessary to compete with even the largest ecommerce companies.

“Carrier coverage is critical to seeing the ROI of visibility, and project44 is dedicated to quickly achieving high compliance percentages for our customers. It has been our goal from day one to build global and multimodal connectivity and serve as the supply chain ecosystem’s connective tissue. This SLA formalizes our commitment, ensuring the entire industry truly understands the power the right visibility solution can have on delivering rapid and enduring results for the world’s leading retailers, manufacturers and distributors,” stated Tommy Barnes, Head of Global Network Partnerships at project44.

By following project44’s implementation program and best practices, project44 will offer the 30-day onboarding SLA with a money back guarantee to shippers in North America and Europe. To learn more about the SLA and project44’s Advanced Visibility Platform™, contact the project44 team today .

About project44

project44 is the world’s only advanced visibility platform for shippers and logistics service providers. project44 connects, automates and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations are able to increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Truckload, Rail, Intermodal, and Ocean. To learn more, visit www.project44.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye